Autoimmune lymphoproliferative syndrome: An inherited or a somatic defect of apoptosis;Le syndrome lymphoprolifératif avec auto-immunité: Un défaut hérité ou acquis d'apoptose lymphocytaire

Medecine/Sciences

Volumn 22, Issue 6-7, 2006, Pages 645-649

  Rieux Laucat, Frédéric ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN;

APOPTOSIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; FAMILY HISTORY; GENE MUTATION; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; LYMPHOCYTE; LYMPHOPROLIFERATIVE DISEASE; MOSAICISM; REVIEW; SIGNAL TRANSDUCTION;

EID: 33745890240     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/20062267645     Document Type: Review

References (21)

1. Canale VC, Smith CH. Chronic lymphadenopathy simulating malignant lymphoma. J Pediatr 1967; 70: 891-9.
2. Rieux-Laucat F, Fischer A, Deist FL. Cell-death signaling and human disease. Curr Opin Immunol 2003; 15: 325-31.
3. Rieux-Laucat F, Le Deist F, Fischer A. Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways. Cell Death Differ 2003; 10: 124-33.
4. Lavrik I, Golks A, Krammer PH. Death receptor signaling. J Cell Sci 2005; 118: 265-7.
5. Peter ME, Krammer PH. The CD95 (APO-1/Fas) DISC and beyond. Cell Death Differ 2003; 10: 26-35.
6. Nagata S, Suda T. Fas and Fas ligand: lpr and gld mutations. Immunol Today 1995; 16: 39-43.
7. Pestano GA, Zhou Y, Trimble LA, et al. Inactivation of misselected CD8 T cells by CD8 gene methylation and cell death. Science 1999; 284: 1187-91.
8. Rieux-Laucat F, Le Deist F, Hivroz C, et al. Mutations in fas associated with human lymphoproliferative syndrome and autoimmunity. Science 1995; 268: 1347-9.
9. Benkerrou M, Le Deist F, de Villartay J, et al. Correction of fas (CD95) deficiency by haploidentical bone marrow transplantation. Eur J Immunol 1997; 27: 2043-7.
10. Rieux-Laucat F, Blachere S, Danielan S, et al. Lymphoproliferative syndrome with autoimmunity: a possible genetic basis for dominant expression of the clinical manifestations. Blood 1999; 94: 2575-82.
11. Vaishnaw AK, Orlinick JR, Chu JL, et al. The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations. J Clin Invest 1999; 103: 355-63.
12. Bleesing JJ, Brown MR, Straus SE, et al. Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome. Blood 2001; 98: 2466-73.
13. Drappa J, Vaishnaw AK, Sullivan KE, et al. Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity. N Engl J Med 1996; 335: 1643-9.
14. Jackson CE, Fischer RE, Hsu AP, et al. Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance. Am J Hum Genet 1999; 64: 1002-14.
15. Morel L, Tian XH, Croker BP, Wakeland EK. Epistatic modifiers of autoimmunity in a murine model of lupus nephritis. Immunity 1999; 11: 131-9.
16. Wang J, Zheng L, Lobito A, et al. Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell 1999; 98: 47-58.
17. Gronbaek K, Dalby T, Zeuthen J, et al. The V410I (G1228A) variant of the caspase-10 gene is a common polymorphism of the Danish population. Blood 2000; 95: 2184-5.
18. Chun HJ, Zheng L, Ahmad M, et al. Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature 2002; 419: 395-9.
19. Su H, Bidere N, Zheng L, et al. Requirement for caspase-8 in NF-kappaB activation by antigen receptor. Science 2005; 307: 1465-8.
20. Salmena L, Lemmers B, Hakem A, et al. Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity. Genes Dev 2003; 17: 883-95.
21. Holzelova E, Vonarbourg C, Stolzenberg MC, et al. Autoimmune lymphoproliferative syndrome with somatic Fas mutations. N Engl J Med 2004; 351: 1409-18.